Viavi Solutions Inc. (NASDAQ:VIAV) is featured in Mad Money’s latest recap as Jim Cramer shared his buy, sell, or hold verdict. A caller sought Cramer’s opinion on the stock, and he remarked: No, I gotta tell you, you’re right, you’re right. I mean, I know it’s expensive, but I’ll tell you, that is the hot area, and I’m not going to disagree with. Let the stock cool a little. I would because the stock was up a couple of bucks today. But yeah, I think you’re onto something with that stock. Stock market ...

Core Viewpoint - Madison Small Cap Fund underperformed in Q4 2025, returning -0.4% compared to the Russell 2000 Index's 2.2% return, with sector allocation, particularly in healthcare, negatively impacting performance [1] Group 1: Fund Performance - The fund's Class I shares returned -0.4% in Q4 2025, lagging behind the benchmark's 2.2% return [1] - The healthcare sector was identified as the weakest performer for the fund during this quarter [1] Group 2: Viavi Solutions Inc. Overview - Viavi Solutions Inc. (NASDAQ:VIAV) is a key investment for the fund, providing network test, monitoring, and assurance solutions across various sectors [2][3] - As of March 12, 2026, Viavi's stock closed at $29.76, with a one-month return of 13.20% and a 52-week gain of 172.03% [2] - Viavi has a market capitalization of $6.89 billion [2] Group 3: Strategic Developments - Viavi Solutions operates through two segments: Network and Service Enablement (NSE) and Optical Security and Performance Products (OSP) [3] - The company made a $1.3 billion bid for Spirent Communications, which was countered by Keysight Technologies at $1.46 billion, leading to antitrust concerns from the U.S. Department of Justice [3] - The DOJ required Keysight to divest overlapping business units to Viavi, which closed on October 16, enhancing Viavi's position in the data center ecosystem and expected to accelerate growth and margin expansion [3] - The market is believed to not fully recognize Viavi's potential in the data center market, with an estimated intrinsic stock value of $30 [3]

Core Insights - Callan JMB Inc. has been invited to the 50th International GMP Conference, highlighting its commitment to the healthcare logistics sector [1][2] - The conference serves as a global platform for discussions on regulatory and pharmaceutical industry advancements, co-sponsored by the University of Georgia and the FDA [2] - Wayne Williams, CEO of Callan JMB, emphasizes the importance of staying at the forefront of healthcare logistics amid rapid technological and regulatory changes [3] Company Overview - Callan JMB Inc. is a vertically integrated logistics company focused on empowering the healthcare industry and emergency management through various logistics services [4] - The company specializes in fulfillment, storage, monitoring, and cold chain logistics to ensure the safety and integrity of medical materials [4] - Callan JMB boasts expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness [4]

Core Viewpoint - Callan JMB Inc. is actively participating in the iAccess Alpha Virtual Best Ideas Spring Investment Conference, highlighting its role in the healthcare logistics sector [1][2]. Company Overview - Callan JMB Inc. is a vertically integrated logistics company focused on empowering the healthcare industry and emergency management agencies through services such as fulfillment, storage, monitoring, and cold chain logistics [3]. - The company aims to secure medical materials and protect patients and communities by providing compliant, safe, and effective medicines [3]. - Callan JMB boasts expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness, positioning itself as a leader in the industry [3]. - The company emphasizes a gold standard in client experience, offering customizable interfaces, reliable shipping, and environmentally sustainable specialty packaging [3].

Company Overview - Viavi Solutions generates revenue through hardware, software, and services for network design, activation, monitoring, and optimization, as well as optical security solutions for anti-counterfeiting and industrial markets [1] - The company provides network test, monitoring, and assurance solutions across three business segments: Network Enablement, Service Enablement, and Optical Security and Performance Products [1] - Viavi Solutions is a leading provider of network testing and assurance solutions with a global customer base across telecommunications, enterprise, and government sectors [5] Recent Transaction - On February 9, 2026, CEO Oleg Khaykin executed a direct open-market sale of 73,250 shares, valued at approximately $1.9 million [4] - This sale reduced Mr. Khaykin's direct holdings by 4.19%, leaving him with 1,635,621 shares directly held and maintaining an aggregate insider ownership of 0.71% [4] - Approximately 73% of Mr. Khaykin's direct ownership position remains available for future transactions after this sale [3] Stock Performance - The sale was executed at around $26.25 per share, while the closing price on February 9, 2026, was $27.62, reflecting a 119.6% one-year total return [2] - Viavi Solutions reported revenue of $369.3 million in its fiscal second quarter ended December 27, 2025, representing a 36% year-over-year growth [7] - The company's stock has reached a multi-year high, with a price-to-sales ratio of about five, indicating a favorable time for selling [8] Market Context - The strong stock performance is attributed to high demand from the data center, aerospace, and defense sectors, particularly due to the artificial intelligence boom [7] - Despite the positive outlook, analysts suggest waiting for a price drop before considering buying the stock, as it is currently at a high valuation [8]

Company Overview - MKS Inc. specializes in providing instruments, systems, and solutions for measuring, monitoring, and controlling manufacturing processes across various industries, including semiconductor, industrial technologies, life and health sciences, research, and defense [1] Stock Performance and Analyst Outlook - The stock consensus target price for MKS Inc. has increased from $198.86 a year ago to $261.67 last month, indicating growing confidence among analysts in the company's performance and future potential [2] - Deutsche Bank has set a price target of $125 for MKS Inc., reflecting a positive outlook for its future performance [3] - MKS Instruments shares have begun to rise, supported by strong revisions in earnings estimates, and are expected to continue their upward trajectory [4] Sector Positioning - The Harbor Small Cap Growth Fund's Q4 2025 portfolio performance highlighted strength in the Industrials and Information Technology sectors, which aligns with MKS Inc.'s operations and positions the company to capitalize on opportunities in these sectors [3]

Group 1 - Viavi Solutions (NASDAQ:VIAV) is recognized as one of the top 11 communication equipment stocks by hedge funds [1] - B. Riley analyst Dave Kang raised the price target for Viavi Solutions from $22 to $26, maintaining a Buy rating after a quarterly report that exceeded consensus estimates [1] - Needham analyst Ryan Koontz also increased his price target for Viavi Solutions from $24 to $28, citing strong quarterly earnings and favorable management guidance, along with expected annual savings of around $30 million from cost-cutting measures [3] Group 2 - Viavi Solutions specializes in network testing, monitoring, and assurance solutions, as well as light-management technologies, serving markets such as telecommunications, cloud, military, and critical infrastructures [4] - The company is expanding its total addressable market through the recent acquisition of Spirent H-S Testing business, positioning itself as a leader in high-speed Ethernet validation [2] - The data center segment is expected to grow by nearly 20%, while other segments are projected to achieve growth rates of 3%-5% [3]

Core Insights - Viavi Solutions, a technology firm specializing in network testing and optical security, reported a significant insider sale by CEO Oleg Khaykin amid strong stock performance, with shares up 106.1% over the past year [1][4][10] Transaction Summary - Oleg Khaykin sold 70,566 shares for approximately $1.9 million, with a post-transaction direct ownership of 1,708,871 shares valued at about $45.1 million [2][6] - The transaction occurred at a market close price of $26.38, reflecting a weighted average purchase price of $26.27 [2][6] Company Overview - Viavi Solutions has a market capitalization of $6.10 billion and generated $1.24 billion in revenue over the trailing twelve months, although it reported a net loss of $41.7 million [4] - The company experienced a 1-year price change of 106.1%, indicating strong capital appreciation [4] Company Operations - Viavi Solutions provides network test, monitoring, and assurance solutions, including hardware, software, and optical security products across three segments: Network Enablement, Service Enablement, and Optical Security and Performance Products [7][8] - The company serves a diverse customer base, including communications service providers, enterprises, and government agencies, focusing on both legacy and next-generation networks [8][9] Market Context - The sale by Mr. Khaykin does not raise concerns as he retains a significant stake in the company, and the transaction aligns with his historical trading patterns [6][10] - The company's stock reached a 52-week high of $26.83 shortly before the sale, reflecting strong market performance [10][11] - Despite the strong sales growth of 36% year-over-year in the fiscal second quarter, the company remains unprofitable, with a net loss of $48.1 million, although this shows significant improvement from the previous year [11]

Core Insights - Callan JMB Inc. is participating in the DealFlow Discovery Conference on January 28-29, 2026, highlighting its role in the healthcare logistics sector [1][2]. Company Overview - Callan JMB Inc. is a vertically integrated logistics company focused on empowering the healthcare industry and emergency management agencies through services such as fulfillment, storage, monitoring, and cold chain logistics [3]. - The company aims to secure medical materials and protect patients and communities by providing compliant, safe, and effective medicines [3]. - Callan JMB boasts expertise in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance, and emergency preparedness, positioning itself as a leader in the industry [3]. - The company emphasizes a gold standard in client experience, offering customizable interfaces, reliable shipping, and environmentally sustainable specialty packaging [3].

Company Overview - Viavi Solutions is a technology company that specializes in network testing, monitoring, and optical security products, serving a global customer base with a diversified business model [1] - The company generates revenue primarily through hardware and software sales, recurring service contracts, and support offerings tailored for communications infrastructure and network optimization [2] Insider Transaction Details - Richard John Burns, a Director at Viavi Solutions, sold 3,384 shares in an open-market transaction on December 10, 2025, which represented 50% of his direct holdings, reducing his position from 6,768 to 3,384 shares [4][5] - The transaction was executed under a pre-established Rule 10b5-1 trading plan, ensuring a systematic approach to the sale [2][9] Impact of the Transaction - Following the sale, Burns's direct ownership in Viavi Solutions stands at 3,384 shares, which is approximately 0.0015% of the outstanding shares [3] - The stock had surged by around 85% over the previous year, reaching a five-year high at the time of the sale, indicating a favorable market condition for the company [5][6] - The current trailing P/E ratio is 292, reflecting past struggles, while the forward P/E ratio is around 29, closely approximating the S&P 500 average of 31, suggesting that while the valuation is not typically a sell signal, profit-taking after a significant run-up is understandable [7]